LTFS
IMGN

Ladenburg Thalmann Financial Services’s Immunogen Inc IMGN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$35K Sell
6,367
-3,296
-34% -$11.2K ﹤0.01% 3789
2019
Q3 		$23K Buy
9,663
+2,986
+45% +$7.93K ﹤0.01% 3964
2019
Q2 		$14K Sell
6,677
-2,209
-25% -$5.22K ﹤0.01% 4282
2019
Q1 		$25K Buy
8,886
+2,570
+41% +$11.1K ﹤0.01% 3866
2018
Q4 		$30K Sell
6,316
-1,988
-24% -$12.1K ﹤0.01% 3627
2018
Q3 		$78K Sell
8,304
-728
-8% -$7K ﹤0.01% 3003
2018
Q2 		$94K Hold
9,032
– – ﹤0.01% 2788
2018
Q1 		$94K Buy
9,032
+413
+5% +$4.08K ﹤0.01% 2788
2017
Q4 		$55K Buy
8,619
+191
+2% +$1.18K ﹤0.01% 3151
2017
Q3 		$64K Buy
8,428
+3,363
+66% +$22.3K ﹤0.01% 2927
2017
Q2 		$36K Buy
5,065
+1,703
+51% +$7.79K ﹤0.01% 3247
2017
Q1 		$13K Sell
3,362
-1,155
-26% -$3.37K ﹤0.01% 3848
2016
Q4 		$9K Sell
4,517
-1,499
-25% -$3.01K ﹤0.01% 3970
2016
Q3 		$16K Buy
6,016
+653
+12% +$1.9K ﹤0.01% 3543
2016
Q2 		$16K Buy
5,363
+362
+7% +$2.27K ﹤0.01% 3499
2016
Q1 		$43K Sell
5,001
-632
-11% -$5.35K ﹤0.01% 2714
2015
Q4 		$77K Buy
5,633
+3,182
+130% +$39.2K ﹤0.01% 2259
2015
Q3 		$24K Buy
2,451
+279
+13% +$4.08K ﹤0.01% 2998
2015
Q2 		$31K Sell
2,172
-977
-31% -$10.7K ﹤0.01% 2935
2015
Q1 		$28K Sell
3,149
-3,470
-52% -$25.1K ﹤0.01% 2975
2014
Q4 		$44K Buy
6,619
+4,101
+163% +$37.5K ﹤0.01% 2450
2014
Q3 		$28K Buy
2,518
+295
+13% +$3.34K ﹤0.01% 2415
2014
Q2 		$27K Sell
2,223
-2,203
-50% -$27.7K ﹤0.01% 2453
2014
Q1 		$68K Buy
4,426
+529
+14% +$8.34K ﹤0.01% 1747
2013
Q4 		$57K Sell
3,897
-2,085
-35% -$32K ﹤0.01% 1827
2013
Q3 		$102K Sell
5,982
-4,626
-44% -$81.3K ﹤0.01% 1386
2013
Q2 		$176K Buy
+10,608
New +$172K 0.01% 1036

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IMGN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Immunogen Inc (IMGN) stake by 34% in Q4 2019, selling an estimated $11.2K and leaving 6,367 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #3789.

Ladenburg Thalmann Financial Services first reported a position in IMGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $176K in Q2 2013. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 6,367 shares of Immunogen Inc worth $35K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 3,296 Immunogen Inc shares in Q4 2019, an estimated $11.2K.
  • Immunogen Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3789 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Immunogen Inc in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Immunogen Inc position peaked at $176K in Q2 2013.
  • 191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.